Multiple Sclerosis and Related Disorders

Skip to Main Content

Abstract Image

Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis

Emma C Tallantyre, Martin J Scurr, Nicola Vickaryous, Aidan Richards, Valerie Anderson, David Baker, Randy Chance, Nikos Evangelou, Katila George, Gavin Giovannoni, Katharine E Harding, Aimee Hibbert, Gillian Ingram, Stephen Jolles, Meleri Jones, Angray S Kang, Samantha Loveless, Stuart J Moat, Neil P Robertson, Francesca Rios, Klaus Schmierer, Mark Willis, Andrew Godkin, Ruth Dobson

DOI: https://doi.org/10.1016/j.msard.2022.103937

Vol. 64

Open Access

Full-Text HTML PDF Supplemental Materials

Abstract Image

Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study

Nik Krajnc, Harald Hegen, Gerhard Traxler, Fritz Leutmezer, Franziska Di Pauli, Barbara Kornek, Paulus Rommer, Gudrun Zulehner, Katharina Riedl, Sophie Dürauer, Angelika Bauer, Sarah Kratzwald, Sigrid Klotz, Michael Winklehner, Florian Deisenhammer, Michael Guger, Romana Höftberger, Thomas Berger, Gabriel Bsteh

DOI: https://doi.org/10.1016/j.msard.2022.104009

Vol. 65

Open Access

Full-Text HTML PDF

Abstract Image

Multiple sclerosis incidence: A systematic review of change over time by geographical region

Jo Lane, Huah Shin Ng, Carmel Poyser, Robyn M Lucas, Helen Tremlett

DOI: https://doi.org/10.1016/j.msard.2022.103932

Vol. 63

Open Access

Full-Text HTML PDF Supplemental Materials

Abstract Image

Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents

Alice Mariottini, Benedetta Forci, Elisa Gualdani, Monica Romoli, Anna Maria Repice, Alessandro Barilaro, Claudia Mechi, Luca Massacesi, Paolo Francesconi

DOI: https://doi.org/10.1016/j.msard.2022.103679

Vol. 60

Open Access

Full-Text HTML PDF

Abstract Image

Aerobic exercise increases irisin serum levels and improves depression and fatigue in patients with relapsing remitting multiple sclerosis: A randomized controlled trial

Furkan Bilek, Nilufer Cetisli-Korkmaz, Zubeyde Ercan, Gulnihal Deniz, Caner Feyzi Demir

DOI: https://doi.org/10.1016/j.msard.2022.103742

Vol. 61

Full-Text HTML PDF

Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression

Chunrong Tao, Steve Simpson-Yap, Bruce Taylor, Leigh Blizzard, Robyn Lucas, Anne-Louise Ponsonby, Simon Broadley, Ingrid van der Mei, AusLong/Ausimmune Investigators Group

DOI: https://doi.org/10.1016/j.msard.2022.103561

Vol. 59

Full-Text HTML PDF Supplemental Materials

Abstract Image

Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England

Afagh Garjani, Sameer Patel, Dhiren Bharkhada, Waqar Rashid, Alasdair Coles, Graham R Law, Nikos Evangelou

DOI: https://doi.org/10.1016/j.msard.2021.103458

Vol. 57

Full-Text HTML PDF Supplemental Materials

Abstract Image

Ultra-high field spinal cord MRI in multiple sclerosis: Where are we standing? A literature review

Daniël J. Kreiter, Job van den Hurk, Christopher J. Wiggins, Raymond M.M. Hupperts, Oliver H.H. Gerlach

DOI: https://doi.org/10.1016/j.msard.2021.103436

Vol. 57

Open Access

Full-Text HTML PDF

Abstract Image

Detection of ataxia in low disability MS patients by hybrid convolutional neural networks based on images of plantar pressure distribution

Ferhat Balgetir, Furkan Bilek, Serkan Kakakus, Seda Arslan-Tuncer, Caner Feyzi Demir

DOI: https://doi.org/10.1016/j.msard.2021.103261

Vol. 56

Full-Text HTML PDF

Abstract Image

Incidence of cancer in multiple sclerosis before and after the treatment era– a registry- based cohort study

Nina Grytten, Kjell-Morten Myhr, Elisabeth G. Celius, Espen Benjaminsen, Margitta T. Kampman, Rune Midgard, Anita Vatne, Jan H. Aarseth, Trond Riise, Øivind Torkildsen

DOI: https://doi.org/10.1016/j.msard.2021.103209

Vol. 55

Open Access

Full-Text HTML PDF

Abstract Image

Can rheumatologists stop causing demyelinating disease?

David Baker, Charalambos Hadjicharalambous, Sharmilee Gnanapavan, Gavin Giovannoni

DOI: https://doi.org/10.1016/j.msard.2021.103057

Vol. 53

Full-Text HTML PDF

Abstract Image

A pilot randomized controlled trial of robotic exoskeleton-assisted exercise rehabilitation in multiple sclerosis

Ghaith J. Androwis, Brian M. Sandroff, Peter Niewrzol, Farris Fakhoury, Glenn R. Wylie, Guang Yue, John DeLuca

DOI: https://doi.org/10.1016/j.msard.2021.102936

Vol. 51

Open Access

Full-Text HTML PDF Supplemental Materials

Abstract Image

Age and sex as determinants of treatment decisions in patients with relapsing-remitting MS

Per Soelberg Sorensen, Tine Iskov Kopp, Hanna Joensen, Anna Olsson, Finn Sellebjerg, Melinda Magyari

DOI: https://doi.org/10.1016/j.msard.2021.102813

Vol. 50

Full-Text HTML PDF Supplemental Materials

Abstract Image

Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness

Barbara Barun, Tereza Gabelić, Ivan Adamec, Antonija Babić, Hrvoje Lalić, Drago Batinić, Magdalena Krbot Skorić, Mario Habek

DOI: https://doi.org/10.1016/j.msard.2020.102704

Vol. 48

Full-Text HTML PDF

Abstract Image

The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation

Francisco Javier Carod-Artal

DOI: https://doi.org/10.1016/j.msard.2020.102657

Vol. 47

Full-Text HTML PDF

Abstract Image

Impact of cervical stenosis on multiple sclerosis lesion distribution in the spinal cord

Daniel Gratch, David Do, Pouya Khankhanian, Matthew Schindler, J Eric Schmitt, Joseph R Berger

DOI: https://doi.org/10.1016/j.msard.2020.102415

Vol. 45

Full-Text HTML PDF

Abstract Image

BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab

E. Signoriello, S. Bonavita, A. Di Pietro, G. Abbadessa, F. Rossi, G. Miele, S. Casertano, G. Lus

DOI: https://doi.org/10.1016/j.msard.2020.102186

Vol. 43

Full-Text HTML PDF

Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update

Elizabeth Silbermann, Angela Senders, Lindsey Wooliscroft, Jessica Rice, Michelle Cameron, Carin Waslo, Anna Orban, Emma Chase, Vijayshree Yadav, Dennis Bourdette, Rebecca I Spain

DOI: https://doi.org/10.1016/j.msard.2020.102041

Vol. 41

Full-Text HTML PDF Supplemental Materials

Abstract Image

Clinical instrument to retrospectively capture levels of EDSS

John Robert Ciotti, Noah Sanders, Amber Salter, Joseph R. Berger, Anne Haney Cross, Salim Chahin

DOI: https://doi.org/10.1016/j.msard.2019.101884

Vol. 39

Full-Text HTML PDF Supplemental Materials

Abstract Image

Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation

Tiina Mustonen, Ilkka Rauma, Päivi Hartikainen, Johanna Krüger, Marja Niiranen, Tuomas Selander, Sakari Simula, Anne M. Remes, Hanna Kuusisto

DOI: https://doi.org/10.1016/j.msard.2019.101498

Vol. 38

Full-Text HTML PDF

Abstract Image

Sirtuins in Multiple Sclerosis: The crossroad of neurodegeneration, autoimmunity and metabolism

Forough Foolad, Fariba Khodagholi, Mohammad Javan

DOI: https://doi.org/10.1016/j.msard.2019.06.004

Vol. 34, p47–58

Full-Text HTML PDF

Abstract Image

An introduction to Mendelian randomization with applications in neurology

Phillip H. Allman, Inmaculada B. Aban, Hemant K. Tiwari, Gary R. Cutter

DOI: https://doi.org/10.1016/j.msard.2018.06.017

Vol. 24, p72–78

Full-Text HTML PDF

Abstract Image

Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder

Maureen A. Mealy, Lawrence J. Cook, Florence Pache, Diego L. Velez, Nadja Borisow, Daniel Becker, Jorge A. Jimenez Arango, Friedemann Paul, Michael Levy

DOI: https://doi.org/10.1016/j.msard.2018.05.003

Vol. 23, p78–82

Full-Text HTML PDF

Abstract Image

Mitochondrial leukoencephalopathies: A border zone between acquired and inherited white matter disorders in children?

Parayil Sankaran Bindu, Kothari Sonam, Shwetha Chiplunkar, Periyasamy Govindaraj, Madhu Nagappa, Chetan Chandrakanth Vekhande, Hanumanthapura R. Aravinda, JN Jessiena Ponmalar, Anita Mahadevan, Narayanappa Gayathri, MM Srinivas Bharath, Sanjib Sinha, Arun B. Taly

DOI: https://doi.org/10.1016/j.msard.2018.01.003

Vol. 20, p84–92

Full-Text HTML PDF Supplemental Materials

Abstract Image

Serious games for arm rehabilitation of persons with multiple sclerosis. A randomized controlled pilot study

Johanna Jonsdottir, Rita Bertoni, Michael Lawo, Angelo Montesano, Thomas Bowman, Silvia Gabrielli

DOI: https://doi.org/10.1016/j.msard.2017.10.010

Vol. 19, p25–29

Full-Text HTML PDF

Effects of cognitive versus motor dual-task on spatiotemporal gait parameters in healthy controls and multiple sclerosis patients with and without fall history

Razieh Mofateh, Reza Salehi, Hossein Negahban, Mohammad Mehravar, Shirin Tajali

DOI: https://doi.org/10.1016/j.msard.2017.09.002

Vol. 18, p8–14

Full-Text HTML PDF

Abstract Image

Is there a change of paradigm towards more effective treatment early in the course of apparent high-risk MS?

Óscar Fernández

DOI: https://doi.org/10.1016/j.msard.2017.07.003

Vol. 17, p75–83

Open Access

Full-Text HTML PDF

EBV and MS: Major cause, minor contribution or red-herring?

Sean Burnard, Jeannette Lechner-Scott, Rodney J. Scott

DOI: https://doi.org/10.1016/j.msard.2017.06.002

Vol. 16, p24–30

Full-Text HTML PDF

Abstract Image

Epstein–Barr virus and multiple sclerosis: Updating Pender's hypothesis

Martin Laurence, Julián Benito-León

DOI: https://doi.org/10.1016/j.msard.2017.05.009

Vol. 16, p8–14

Full-Text HTML PDF

Abstract Image

Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation

Ulrike W. Kaunzner, Yeona Kang, Elizabeth Monohan, Paresh J. Kothari, Nancy Nealon, Jai Perumal, Timothy Vartanian, Amy Kuceyeski, Shankar Vallabhajosula, P. David Mozley, Claire S. Riley, Stephen M. Newman, Susan A. Gauthier

DOI: https://doi.org/10.1016/j.msard.2017.04.008

Vol. 15, p27–33

Full-Text HTML PDF Supplemental Materials

Abstract Image

Hospitalization is associated with subsequent disability in multiple sclerosis

Allan Garland, Luanne M. Metz, Charles N. Bernstein, Christine A. Peschken, Carol A. Hitchon, Ruth Ann Marrie

DOI: https://doi.org/10.1016/j.msard.2017.03.009

Vol. 14, p23–28

Open Access

Full-Text HTML PDF Supplemental Materials

Abstract Image

Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study

K. O’Connell, N. Tubridy, M. Hutchinson, C. McGuigan

DOI: https://doi.org/10.1016/j.msard.2017.02.010

Vol. 13, p75–80

Full-Text HTML PDF

Should we rebrand multiple sclerosis a dementia?

Gavin Giovannoni

DOI: https://doi.org/10.1016/j.msard.2017.01.008

Vol. 12, p79–81

Full-Text HTML PDF

Abstract Image

Novel Zebrafish EAE model: A quick in vivo screen for multiple sclerosis

Pushkar Kulkarni, Swapna Yellanki, Raghavender Medishetti, Dharmarajan Sriram, Uday Saxena, Perumal Yogeeswari

DOI: https://doi.org/10.1016/j.msard.2016.11.010

Vol. 11, p32–39

Full-Text HTML PDF Supplemental Materials

Abstract Image

Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up

Carrie M. Hersh, Thomas E. Love, Samuel Cohn, Claire Hara-Cleaver, Robert A. Bermel, Robert J. Fox, Jeffrey A. Cohen, Daniel Ontaneda

DOI: https://doi.org/10.1016/j.msard.2016.08.002

Vol. 10, p44–52

Full-Text HTML PDF

Abstract Image

CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis – Targeting T or B cells?

Marie Colombe Agahozo, Laura Peferoen, David Baker, Sandra Amor

DOI: https://doi.org/10.1016/j.msard.2016.07.011

Vol. 9, p110–117

Full-Text HTML PDF

Abstract Image

Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis

Jack van Horssen, Susanne van der Pol, Philip Nijland, Sandra Amor, Hervé Perron

DOI: https://doi.org/10.1016/j.msard.2016.04.006

Vol. 8, p11–18

Open Access

Full-Text HTML PDF Supplemental Materials

Abstract Image

Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients

Nicola De Stefano, Davorka Tomic, Ernst-Wilhelm Radue, Till Sprenger, Daniela Piani Meier, Dieter Häring, Maria Pia Sormani

DOI: https://doi.org/10.1016/j.msard.2016.03.017

Vol. 7, p98–101

Full-Text HTML PDF

Abstract Image

Relapses in multiple sclerosis: Relationship to disability

Douglas S. Goodin, Anthony T. Reder, Robert A. Bermel, Gary R. Cutter, Robert J. Fox, Gareth R. John, Fred D. Lublin, Claudia F. Lucchinetti, Aaron E. Miller, Daniel Pelletier, Michael K. Racke, Bruce D. Trapp, Timothy Vartanian, Emmanuelle Waubant

DOI: https://doi.org/10.1016/j.msard.2015.09.002

Vol. 6, p10–20

Full-Text HTML PDF

Abstract Image

Reducing clinical trial risk in multiple sclerosis

C.D. De Gasperis-Brigante, J.L. Parker, P.W. O’Connor, T.R. Bruno

DOI: https://doi.org/10.1016/j.msard.2015.11.007

Vol. 5, p81–88

Full-Text HTML PDF

Abstract Image

Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesion

Mohammad Abdoli, Mark S. Freedman

DOI: https://doi.org/10.1016/j.msard.2015.07.013

Vol. 4, Issue 6, p555–566

Full-Text HTML PDF

Abstract Image

Causes of death among persons with multiple sclerosis

Gary R. Cutter, Jeffrey Zimmerman, Amber R. Salter, Volker Knappertz, Gustavo Suarez, John Waterbor, Virginia J. Howard, Ruth Ann Marrie

DOI: https://doi.org/10.1016/j.msard.2015.07.008

Vol. 4, Issue 5, p484–490

Full-Text HTML PDF Supplemental Materials

Abstract Image

Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

Gavin Giovannoni, Benjamin Turner, Sharmilee Gnanapavan, Curtis Offiah, Klaus Schmierer, Monica Marta

DOI: https://doi.org/10.1016/j.msard.2015.04.006

Vol. 4, Issue 4, p329–333

Open Access

Full-Text HTML PDF

Smoke and mirrors: Limited value of relative risk reductions for assessing the benefits of disease-modifying therapies for multiple sclerosis

Magd Zakaria

DOI: https://doi.org/10.1016/j.msard.2015.03.009

Vol. 4, Issue 3, p187–191

Full-Text HTML PDF

Abstract Image

Multiple sclerosis: The role of melatonin and N-acetylserotonin

George Anderson, Moses Rodriguez

DOI: https://doi.org/10.1016/j.msard.2014.12.001

Vol. 4, Issue 2, p112–123

Full-Text HTML PDF

Abstract Image

Patients report worse MS symptoms after menopause: Findings from an online cohort

R. Bove, B.C. Healy, E. Secor, T. Vaughan, B. Katic, T. Chitnis, P. Wicks, P.L. De Jager

DOI: https://doi.org/10.1016/j.msard.2014.11.009

Vol. 4, Issue 1, p18–24

Full-Text HTML PDF Supplemental Materials

Economic costs associated with an MS relapse

K. O׳Connell, S.B. Kelly, E. Fogarty, M. Duggan, L. Buckley, M. Hutchinson, C. McGuigan, N. Tubridy

DOI: https://doi.org/10.1016/j.msard.2014.09.002

Vol. 3, Issue 6, p678–683

Full-Text HTML PDF

Abstract Image

P wave duration and dispersion and QT interval in multiple sclerosis

Nazanin Razazian, Neda Hedayati, Nasrin Moradian, Arash Bostani, Daryoush Afshari, Nader Asgari

DOI: https://doi.org/10.1016/j.msard.2014.05.001

Vol. 3, Issue 5, p662–665

Full-Text HTML PDF

Abstract Image

Progressive multifocal leukoencephalopathy and JC Virus-related disease in modern neurology practice

Robert L. Carruthers, Joseph Berger

DOI: https://doi.org/10.1016/j.msard.2014.01.005

Vol. 3, Issue 4, p419–430

Full-Text HTML PDF

Abstract Image

Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S.

D.W. Kaufman, S. Reshef, H.L. Golub, M. Peucker, M.J. Corwin, D.S. Goodin, V. Knappertz, D. Pleimes, G. Cutter

DOI: https://doi.org/10.1016/j.msard.2013.12.003

Vol. 3, Issue 3, p364–371

Full-Text HTML PDF

Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis

D.R. Altmann, T. Button, K. Schmierer, K. Hunter, D.J. Tozer, C.A. Wheeler-Kingshott, A. Coles, D.H. Miller

DOI: https://doi.org/10.1016/j.msard.2013.09.007

Vol. 3, Issue 2, p237–243

Full-Text HTML PDF

Abstract Image

Vitamin A is not associated with exacerbations in multiple sclerosis

T.F. Runia, W.C.J. Hop, Y.B. de Rijke, R.Q. Hintzen

DOI: https://doi.org/10.1016/j.msard.2013.06.011

Vol. 3, Issue 1, p34–39

Open Access

Full-Text HTML PDF

Abstract Image

An agent-based simulation model for informed shared decision making in multiple sclerosis

Mário Veloso

DOI: https://doi.org/10.1016/j.msard.2013.04.001

Vol. 2, Issue 4, p377–384

Open Access

Full-Text HTML PDF

Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

RELX